该项收购完成后,Cambrex公司将获得Avista公司包括从原料药、药品开发、环化核苷酸制造,到独立分析、微生物测验以及固态科学等多项服务,同时将Avista的4个制药站点纳入其生...查看全文
琬麟2015-02-07 09:21
$凯姆布雷克斯(CBM)$ EAST RUTHERFORD, N.J., Feb. 6, 2015 /PRNewswire/ -- Cambrex Corporation (NYSE: CBM, "Cambrex") is pleased to announce that it has initiated the second significant expansion of its Charles City, Iowa facility in less than three years. Strong continu...查看全文
$凯姆布雷克斯(CBM)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-19-059249 Size: 31 KB 网页链接
$凯姆布雷克斯(CBM)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-19-059240 Size: 9 KB 网页链接
$凯姆布雷克斯(CBM)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-19-059241 Size: 20 KB 网页链接
$凯姆布雷克斯(CBM)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-19-059242 Size: 24 KB 网页链接
$凯姆布雷克斯(CBM)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-19-059243 Size: 20 KB 网页链接
$凯姆布雷克斯(CBM)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-19-059244 Size: 28 KB 网页链接
$凯姆布雷克斯(CBM)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-19-059245 Size: 31 KB 网页链接
$凯姆布雷克斯(CBM)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-19-059238 Size: 16 KB 网页链接
$凯姆布雷克斯(CBM)$ 8-K Current report, items 1.02, 2.01, 3.01, 3.03, 5.01, 5.02, 5.03, 7.01, and 9.01 Accession Number: 0001193125-19-306490 Act: 34 Size: 336 KB 网页链接
$凯姆布雷克斯(CBM)$ 25-NSE Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities Accession Number: 0000876661-19-001217 Act: 34 Size: 4 KB 网页链接